[Results of neuroleukemia prevention in children with acute lymphoblastic leukemia]. 1991

S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov

The follow-up of 318 children with acute lymphoblastic leukemia given program therapy that included different treatments including chemo- and radioprevention of neuroleukemia demonstrated the high efficacy of the measures carried out, which reduced the incidence of neuroleukemia to 5.6%. No gross changes on the part of the neuropsychic status were revealed in the course of the follow-up of children who received the combined prophylaxis of neuroleukemia. The derangement of the CNS was recorded in 17 patients and ran its course in the form of leukemic meningitis and meningoencephalitis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008577 Meningeal Neoplasms Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord. Intracranial Meningeal Neoplasms,Spinal Meningeal Neoplasms,Benign Meningeal Neoplasms,Leptomeningeal Neoplasms,Malignant Meningeal Neoplasms,Meningeal Cancer,Meningeal Neoplasms, Benign,Meningeal Neoplasms, Intracranial,Meningeal Neoplasms, Malignant,Meningeal Tumors,Neoplasms, Leptomeningeal,Neoplasms, Meningeal,Benign Meningeal Neoplasm,Cancer, Meningeal,Cancers, Meningeal,Intracranial Meningeal Neoplasm,Leptomeningeal Neoplasm,Malignant Meningeal Neoplasm,Meningeal Cancers,Meningeal Neoplasm,Meningeal Neoplasm, Benign,Meningeal Neoplasm, Intracranial,Meningeal Neoplasm, Malignant,Meningeal Neoplasm, Spinal,Meningeal Neoplasms, Spinal,Meningeal Tumor,Neoplasm, Benign Meningeal,Neoplasm, Intracranial Meningeal,Neoplasm, Leptomeningeal,Neoplasm, Malignant Meningeal,Neoplasm, Meningeal,Neoplasm, Spinal Meningeal,Neoplasms, Benign Meningeal,Neoplasms, Intracranial Meningeal,Neoplasms, Malignant Meningeal,Neoplasms, Spinal Meningeal,Spinal Meningeal Neoplasm,Tumor, Meningeal,Tumors, Meningeal
D008590 Meningoencephalitis An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions. Cerebromeningitis,Encephalomeningitis,Cerebromeningitides,Encephalomeningitides,Meningoencephalitides
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
June 1975, Meditsinskaia radiologiia,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
January 1980, Ceskoslovenska pediatrie,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
January 1999, Terapevticheskii arkhiv,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
April 1985, Gematologiia i transfuziologiia,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
March 1993, Gematologiia i transfuziologiia,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
November 2006, International journal of pediatric otorhinolaryngology,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
February 1987, Gematologiia i transfuziologiia,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
January 1987, Revista chilena de pediatria,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
March 1979, International journal of radiation oncology, biology, physics,
S A Maiakova, and E I Moiseenko, and V I Tsygankin, and E V Vil'chevskaia, and L V Bondarenko, and E I Kuznetsova, and T I Zaĭtseva, and O M Meluzova, and G V Lobanov
January 1979, Archives francaises de pediatrie,
Copied contents to your clipboard!